Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials.

Signorovitch, James E

Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials. [electronic resource] - Current medical research and opinion Jun 2011 - 1263-71 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1473-4877

10.1185/03007995.2011.576238 doi


Aged
Antineoplastic Agents--therapeutic use
Dasatinib
Female
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyrimidines--therapeutic use
Thiazoles--therapeutic use
Treatment Outcome